Buscar
Genenta Science SPA
GNTAAñadir a la lista de seguimiento
1.334USD
+0.034+2.65%
Horarios del mercado （ET）Cotizaciones retrasadas 15 min
31.27MCap. mercado
PérdidaP/E TTM
Más Datos de Genenta Science SPA Compañía
Genenta Science SpA is an Italy-based company engaged in clinical-stage biotechnology research. The Company focuses on the development of lentivirus-based gene and cell therapies in cancer. It uses gene-based cytokine delivery to activate the immune system within the tumor providing the anti-tumor response. The Company not only operates locally but also is present in global markets, including the United States.
Perfil de Genenta Science SPA
Símbolo de cotizaciónGNTA
Nombre de la empresaGenenta Science SPA
Fecha de salida a bolsaDec 15, 2021
Director ejecutivoParacchi (Pierluigi)
Número de empleados13
Tipo de seguridadDepository Receipt
Fin del año fiscalDec 15
DirecciónVia Olgettina 58
CiudadMILANO
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísItaly
Código postal20132
Teléfono
Sitio Webhttps://www.genenta.com/
Símbolo de cotizaciónGNTA
Fecha de salida a bolsaDec 15, 2021
Director ejecutivoParacchi (Pierluigi)
Ejecutivos de Genenta Science SPA
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Pierluigi Paracchi
Mr. Pierluigi Paracchi
Chairman of the Board, Chief Executive Officer, General Manager
Chairman of the Board, Chief Executive Officer, General Manager
2.43M
+5.34%
Mr. Pierluigi Paracchi
Mr. Pierluigi Paracchi
Chairman of the Board, Chief Executive Officer, General Manager
Chairman of the Board, Chief Executive Officer, General Manager
2.43M
+5.34%
Dr. Carlo Russo, M.D.
Dr. Carlo Russo, M.D.
Chief Medical Officer, Head of Development
Chief Medical Officer, Head of Development
602.42K
+0.66%
Dr. Carlo Russo, M.D.
Dr. Carlo Russo, M.D.
Chief Medical Officer, Head of Development
Chief Medical Officer, Head of Development
602.42K
+0.66%
Mr. Richard B. Slansky
Mr. Richard B. Slansky
Chief Financial Officer
Chief Financial Officer
22.15K
--
Mr. Richard B. Slansky
Mr. Richard B. Slansky
Chief Financial Officer
Chief Financial Officer
22.15K
--
Dr. Stefania Mazzoleni, Ph.D.
Dr. Stefania Mazzoleni, Ph.D.
Scientific Project Manager, Communication Officer
Scientific Project Manager, Communication Officer
--
--
Dr. John Louis Cantello, Ph.D.
Dr. John Louis Cantello, Ph.D.
Independent Director
Independent Director
--
--
Dr. Lauren Haeyong Chung, Ph.D.
Dr. Lauren Haeyong Chung, Ph.D.
Independent Director
Independent Director
--
--
Dr. Armon Reza Sharei, Ph.D.
Dr. Armon Reza Sharei, Ph.D.
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Pierluigi Paracchi
Mr. Pierluigi Paracchi
Chairman of the Board, Chief Executive Officer, General Manager
Chairman of the Board, Chief Executive Officer, General Manager
2.43M
+5.34%
Mr. Pierluigi Paracchi
Mr. Pierluigi Paracchi
Chairman of the Board, Chief Executive Officer, General Manager
Chairman of the Board, Chief Executive Officer, General Manager
2.43M
+5.34%
Dr. Carlo Russo, M.D.
Dr. Carlo Russo, M.D.
Chief Medical Officer, Head of Development
Chief Medical Officer, Head of Development
602.42K
+0.66%
Dr. Carlo Russo, M.D.
Dr. Carlo Russo, M.D.
Chief Medical Officer, Head of Development
Chief Medical Officer, Head of Development
602.42K
+0.66%
Mr. Richard B. Slansky
Mr. Richard B. Slansky
Chief Financial Officer
Chief Financial Officer
22.15K
--
Mr. Richard B. Slansky
Mr. Richard B. Slansky
Chief Financial Officer
Chief Financial Officer
22.15K
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Genenta Science SPA?
Los cinco principales accionistas de Genenta Science SPA son: Mr. Pierluigi Paracchi
¿Cuántas instituciones poseen acciones de Genenta Science SPA (GNTA)?
A fecha de 2026Q1, 24 instituciones poseen acciones de Genenta Science SPA, con un valor de mercado combinado de aproximadamente 3.34M, lo que representa el 14.15% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en 1015532.00.